Specifically, O-GlcNAcylation of the glycolytic enzyme phosphofructokinase (PFK-1), a key regulatory enzyme in the glycolytic pathway, inhibits PFK-1 activity and diverts glycolytic flux toward the PPP, proving advantageous for cancer growth under conditions of oxidative stress [92]. The gene discussed is PFKM; the disease is cancer.